Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models by Annie De Groot | Aug 2, 2019Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models
Highly Immunogenic Vaccine For Prevention and Therapy of Malignant Mesothelioma by Adam | Oct 21, 2016
